Trials / Completed
CompletedNCT01715558
Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2
Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 514 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to demonstrate that reduction of unnecessary pacing provided by RYTHMIQ algorithm programed to ON in a pacemaker is associated with better clinical outcomes in bradycardia target population.
Conditions
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2012-10-29
- Last updated
- 2017-05-09
Locations
39 sites across 9 countries: Belgium, Denmark, France, Germany, Italy, Netherlands, Slovakia, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01715558. Inclusion in this directory is not an endorsement.